Your Daily News Roundup

Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!

Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better handle the ongoing COVID-19 coronavirus pandemic.

We’re taking the opportunity each week to share some of those resources that may help people get through this challenging time with the help of partners and experts.

We will be sharing the most recent, most relevant behavior change content from Beyond Type 1, JDRF, and more!

Take a look! 

This week, we’re focusing on legislation that has the potential to help keep our community safe until we’re all safe, and resources to help our community weigh and mitigate risks as they head back into society.

Here are some of the stories to keep an eye on this week.

Check out these articles:


  • New preliminary data from the T1D Exchange suggest that although hyperglycemia and diabetic ketoacidosis (DKA) are common in people with type 1 diabetes who develop COVID-19, many are still able to manage the illness at home and overall mortality is relatively low.  Click here to read more insights into how half of those with COVID-19 and Type 1 diabetes manage the virus at home.  

Here are a few of the most exciting and important resources that we’ve seen about this topic in the last few weeks — we’ll be updating the list regularly as time goes on!

This image has an empty alt attribute; its file name is divider_t1d-exchange.png

T1D Exchange is pleased to announce the preliminary results of its population health surveillance study, “Type 1 Diabetes and COVID-19: Preliminary Findings from a Multi-Center Surveillance Study in the United States,” recently published in Diabetes Care, the peer-reviewed medical journal of the American Diabetes Association.

The study focuses on individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). This is the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19. 

This image has an empty alt attribute; its file name is divider_beyond-type-1.png
  • SUMMER IS HERE: ARE YOU STILL SAFER AT HOME? Read this piece on Weighing risks of exposure and how we can make smart choices. 

The American Diabetes Association (ADA) 

  • The COVID-19 Testing, Reaching and Contacting Everyone (TRACE) Act helps local organizations create mobile testing units and conduct door-to-door outreach with a special preference for hot spots and underserved communities.
  • The Affordable Insulin for the COVID-19 Emergency Act would eliminate insulin cost-sharing for seniors living with diabetes enrolled in Medicare Part D during the COVID-19 emergency. Seniors would also be able to obtain a 90-day supply of insulin by mail to avoid the risk of going to the pharmacy.